Endy:Screening plasmid
From OpenWetWare
(Difference between revisions)
(→Screening Plasmid 1.0) |
|||
| Line 35: | Line 35: | ||
We are in the process of designing a new version of the screening plasmid to account for some of the shortcomings of the previous version. Details can be found here: | We are in the process of designing a new version of the screening plasmid to account for some of the shortcomings of the previous version. Details can be found here: | ||
*[[Endy:Screening plasmid 2.0|Screening Plasmid 2.0]] | *[[Endy:Screening plasmid 2.0|Screening Plasmid 2.0]] | ||
| + | |||
| + | ==Documents== | ||
| + | *[[/Registry technical report/]] | ||
==References== | ==References== | ||
Revision as of 11:53, 20 March 2007
This page is a work in progress.
Introduction
The screening plasmid is designed to enable fast characterization of PoPS-based parts and devices. It consists of 4 components: (1) Tunable input (2) Input measurement (3) Part/Device insertion site (4) Output measurement.
Screening Plasmid 1.0
Design of Screening Plasmid 1.0: We are using the Pbad arabinose-inducible induction system [1] as a tunable input. GFP is a measure of input and RFP is a measure of output. A Biobricks cloning site enables easy insertion of any Biobricks part. RNase E sites create independence between the mRNA stability of the device being screened and the mRNA stability of the fluorescent proteins. In particular, we suspect mRFP1 contains internal RNaseE cut sites and have added a hairpin 5’ of the coding region to slow degradation by RNase E. [2]
Terminator Characterization via Screening Plasmid 1.0
Characterization of 6 terminators from the Registry of Standard Biological Parts inserted into the Screening Plasmid. The black line is the best fit to the empty screening plasmid, and serves as a standard for 0% termination efficiency. Functional terminators should lie below the line, note that B0025 (red) is sometimes acting as a promoter.
Inverter Characterization via Screening Plasmid 1.0
Screening Plasmid 2.0
We are in the process of designing a new version of the screening plasmid to account for some of the shortcomings of the previous version. Details can be found here:
Documents
References
- Khlebnikov A, Skaug T, and Keasling JD. . pmid:12080425.
- Smolke CD and Keasling JD. . pmid:12402322.


